Fractalkine mediates inflammatory pain through activation of satellite glial cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 27, 2013, Pages 11193-11198

  Souza, Guilherme R ^a   Talbot, Jhimmy ^a   Lotufo, Celina M ^a,b   Cunha, Fernando Q ^a   Cunha, Thiago M ^a   Ferreira, Sérgio H ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

Author keywords

Cytokines; Hyperalgesia; Nociception; Primary sensitization

Indexed keywords

CARRAGEENAN; CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; INDOMETACIN; INTERLEUKIN 1BETA; MESSENGER RNA; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; GLIA CELL; HINDLIMB; HYPERALGESIA; IN VITRO STUDY; INFLAMMATORY PAIN; INHIBITION KINETICS; MALE; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; REAL TIME POLYMERASE CHAIN REACTION; SATELLITE CELL; SIGNAL TRANSDUCTION; SPINAL GANGLION;

CYTOKINES; HYPERALGESIA; NOCICEPTION; PRIMARY SENSITIZATION;

ANIMALS; CHEMOKINE CX3CL1; CYTOKINES; DINOPROSTONE; GANGLIA, SPINAL; GLIAL FIBRILLARY ACIDIC PROTEIN; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MODELS, NEUROLOGICAL; NEUROGLIA; NOCICEPTION; PAIN; PAIN THRESHOLD; RATS; RATS, WISTAR; SATELLITE CELLS, PERINEURONAL;

RATTUS;

EID: 84879731409     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1307445110     Document Type: Article

References (45)

1. Ferreira SH (1972) Prostaglandins, aspirin-like drugs and analgesia. Nat New Biol 240(102):200-203.
2. Verri WA, Jr., et al. (2006) Hypernociceptive role of cytokines and chemokines: Targets for analgesic drug development? Pharmacol Ther 112(1):116-138.
3. Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH (1992) The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 107(3):660-664.
4. Cunha TM, et al. (2005) A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc Natl Acad Sci USA 102(5):1755-1760. (Pubitemid 40209240)
5. Park CK, et al. (2011) Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: Distinct roles of resolvin D1, D2, and E1. J Neurosci 31(50):18433-18438.
6. Takeda M, Takahashi M, Nasu M, Matsumoto S (2011) Peripheral inflammation suppresses inward rectifying potassium currents of satellite glial cells in the trigeminal ganglia. Pain 152(9):2147-2156.
7. Watkins LR, Milligan ED, Maier SF (2001) Glial activation: A driving force for pathological pain. Trends Neurosci 24(8):450-455. (Pubitemid 32695356)
8. Hanani M (2005) Satellite glial cells in sensory ganglia: from form to function. Brain Res Brain Res Rev 48(3):457-476.
9. Ferrari LF, Cunha FQ, Parada CA, Ferreira SH (2007) A novel technique to perform direct intraganglionar injections in rats. J Neurosci Methods 159(2):236-243. (Pubitemid 44914091)
10. Bazan JF, et al. (1997) A new class of membrane-bound chemokine with a CX3C motif. Nature 385(6617):640-644.
11. Pan Y, et al. (1997) Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 387(6633):611-617. (Pubitemid 27248766)
12. Chapman GA, et al. (2000) Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. J Neurosci 20(15):RC87.
13. Verge GM, et al. (2004) Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. Eur J Neurosci 20(5):1150-1160. (Pubitemid 39233569)
14. Zhang F, et al. (2008) Selective activation of microglia in spinal cord but not higher cortical regions following nerve injury in adult mouse. Mol Pain 4:15.
15. Garrison CJ, Dougherty PM, Kajander KC, Carlton SM (1991) Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury. Brain Res 565(1):1-7.
16. Liu FY, et al. (2012) Activation of satellite glial cells in lumbar dorsal root ganglia contributes to neuropathic pain after spinal nerve ligation. Brain Res 1427:65-77.
17. Clark AK, et al. (2007) Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proc Natl Acad Sci USA 104(25):10655-10660. (Pubitemid 47185720)
18. Milligan ED, et al. (2004) Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. Eur J Neurosci 20(9):2294-2302. (Pubitemid 39472392)
19. Guo W, et al. (2007) Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci 27(22):6006-6018. (Pubitemid 46849761)
20. Villa G, et al. (2010) Temporomandibular joint inflammation activates glial and immune cells in both the trigeminal ganglia and in the spinal trigeminal nucleus. Mol Pain 6:89.
21. Milligan ED, Watkins LR (2009) Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 10(1):23-36.
22. Funez MI, et al. (2008) Teleantagonism: A pharmacodynamic property of the primary nociceptive neuron. Proc Natl Acad Sci USA 105(49):19038-19043.
23. Siemionow K, Klimczak A, Brzezicki G, Siemionow M, & McLain RF (2009) The effects of inflammation on glial fibrillary acidic protein expression in satellite cells of the dorsal root ganglion. Spine (Phila Pa 1976) 34(16):1631-1637.
24. Zhang H, et al. (2009) Altered functional properties of satellite glial cells in compressed spinal ganglia. Glia 57(15):1588-1599.
25. Takeda M, Takahashi M, Matsumoto S (2008) Contribution of activated interleukin receptors in trigeminal ganglion neurons to hyperalgesia via satellite glial interleukin-1beta paracrine mechanism. Brain Behav Immun 22(7):1016-1023.
26. Milligan ED, Sloane EM, Watkins LR (2008) Glia in pathological pain: A role for fractalkine. J Neuroimmunol 198(1-2):113-120.
27. Clark AK, Yip PK, Malcangio M (2009) The liberation of fractalkine in the dorsal horn requires microglial cathepsin S. J Neurosci 29(21):6945-6954.
28. Staniland AA, et al. (2010) Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice. J Neurochem 114(4):1143-1157.
29. Zhuang ZY, et al. (2007) Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav Immun 21(5):642-651.
30. Wen YR, et al. (2007) Nerve conduction blockade in the sciatic nerve prevents but does not reverse the activation of p38 mitogen-activated protein kinase in spinal microglia in the rat spared nerve injury model. Anesthesiology 107(2):312-321.
31. Xie W, Strong JA, Zhang JM (2009) Early blockade of injured primary sensory afferents reduces glial cell activation in two rat neuropathic pain models. Neuroscience 160(4):847-857.
32. Samad TA, et al. (2001) Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410(6827):471-475. (Pubitemid 32240046)
33. Usachev YM, Thayer SA (1999) Controlling the urge for a Ca(2+) surge: All-or-none Ca(2+) release in neurons. Bioessays 21(9):743-750. (Pubitemid 29427362)
34. Smith JA, Davis CL, Burgess GM (2000) Prostaglandin E2-induced sensitization of bradykinin-evoked responses in rat dorsal root ganglion neurons is mediated by cAMP-dependent protein kinase A. Eur J Neurosci 12(9):3250-3258.
35. Kawasaki Y, et al. (2008) Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med 14(3):331-336. (Pubitemid 351347915)
36. Ji RR, Xu ZZ, Wang X, Lo EH (2009) Matrix metalloprotease regulation of neuropathic pain. Trends Pharmacol Sci 30(7):336-340.
37. Takeda M, Takahashi M, Matsumoto S (2009) Contribution of the activation of satellite glia in sensory ganglia to pathological pain. Neurosci Biobehav Rev 33(6):784-792.
38. Safieh-Garabedian B, Poole S, Allchorne A, Winter J, Woolf CJ (1995) Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol 115(7):1265-1275.
39. Takeda M, et al. (2007) Enhanced excitability of nociceptive trigeminal ganglion neurons by satellite glial cytokine following peripheral inflammation. Pain 129(1-2):155-166. (Pubitemid 46551374)
40. Hu P, McLachlan EM (2002) Macrophage and lymphocyte invasion of dorsal root ganglia after peripheral nerve lesions in the rat. Neuroscience 112(1):23-38. (Pubitemid 34603495)
41. Wagner R, Myers RR (1996) Schwann cells produce tumor necrosis factor alpha: Expression in injured and non-injured nerves. Neuroscience 73(3):625-629. (Pubitemid 26260924)
42. Holmes FE, et al. (2008) Intra-neural administration of fractalkine attenuates neuropathic pain-related behaviour. J Neurochem 106(2):640-649.
43. Vivancos GG, et al. (2004) An electronic pressure-meter nociception paw test for rats. Braz J Med Biol Res 37(3):391-399. (Pubitemid 38444530)
44. Linhart O, Obreja O, Kress M (2003) The inflammatory mediators serotonin, prostaglandin E2 and bradykinin evoke calcium influx in rat sensory neurons. Neuroscience 118(1):69-74. (Pubitemid 36369531)
45. Cunha TM, et al. (2008) Crucial role of neutrophils in the development of mechanical inflammatory hypernociception. J Leukoc Biol 83(4):824-832. (Pubitemid 351959862) São Paulo Inflamatórias